Penicillin kills bacteria by targeting the machinery they use to build and maintain their cell walls, and its ability to do this traces back to a single structural feature: a strained, four-membered ring called the beta-lactam ring. That ring mimics part of the building material bacteria need, slipping into their construction enzymes and jamming them shut. Understanding how this works, how fungi produce penicillin in the first place, and how bacteria have learned to fight back gives a surprisingly complete picture of one of the most important drugs in human history.
The Beta-Lactam Ring and Why It Matters
Every penicillin molecule shares a core scaffold: a four-membered beta-lactam ring fused to a five-membered thiazolidine ring. The beta-lactam ring is the business end. Its shape is unnaturally strained, meaning the bonds holding it together are under tension, ready to snap open and react with nearby targets. That chemical instability is a feature, not a bug. When the ring opens, it forms a permanent bond with a specific kind of enzyme inside bacterial cells, disabling it. Without a functional beta-lactam ring, the molecule loses essentially all antibacterial activity.
What distinguishes one penicillin from another is the side chain attached to this shared core. Natural penicillin G, for instance, carries a benzyl group. Penicillin V has a phenoxyacetyl group. These side chains influence how well the drug is absorbed, how long it lasts in the body, and which bacteria it can reach. But the killing mechanism is the same across all penicillins: the beta-lactam ring opens and latches onto its target.
How Penicillin Kills Bacteria
The targets penicillin goes after are enzymes called penicillin-binding proteins, or PBPs. These enzymes do the critical work of cross-linking strands of peptidoglycan, the mesh-like polymer that gives a bacterial cell wall its rigidity. Without proper cross-linking, the wall weakens. PBPs have been the target of beta-lactam antibiotics for decades precisely because they are so essential to bacterial survival.1PubMed Central. Penicillin-binding protein (PBP) inhibitor development: A 10-year chemical perspective
Penicillin works because the beta-lactam ring structurally resembles the natural substrate that PBPs act on. The enzyme grabs penicillin, the ring opens, and a covalent bond forms between the drug and the enzyme’s active site. That bond is essentially permanent on a biological timescale. The PBP is now stuck, unable to cross-link any more peptidoglycan strands.2PubMed Central. The Penicillin-Binding Protein PbpP Is a Sensor of β-Lactams and Is Required for Activation of the Extracytoplasmic Function σ Factor σ(P) in Bacillus thuringiensis
But here is a detail that often surprises people: jamming PBPs does not directly kill the bacterium. It stops the cell from growing properly, but actual death requires a second step. The bacterium’s own self-destruct enzymes, called autolysins, finish the job. Under normal conditions, autolysins help remodel the cell wall during growth, carefully breaking bonds so new material can be inserted. When penicillin cripples the construction side of this process, the demolition side keeps running unchecked, and the wall disintegrates.3PubMed. Signal transduction by a death signal peptide: uncovering the mechanism of bacterial killing by penicillin
Research in the pneumonia-causing bacterium Streptococcus pneumoniae has revealed a more specific version of this process. During normal exponential growth, these cells produce lipid-anchored surface polymers that sequester the major autolysin LytA, keeping it away from the cell wall. When penicillin treatment disrupts wall synthesis, it triggers degradation of a key enzyme responsible for making those polymers. The cell switches to producing wall-anchored versions instead, which frees LytA to attack the peptidoglycan. The weakened wall then ruptures under osmotic pressure.4eLife. A switch in surface polymer biogenesis triggers growth-phase-dependent and antibiotic-induced bacteriolysis
How Fungi Make Penicillin
Penicillin is produced naturally by certain filamentous fungi, most famously Penicillium chrysogenum (now reclassified as Penicillium rubens). The biosynthesis pathway involves three main enzymatic steps, and the genes encoding them are clustered together on the fungal chromosome.
The first step is the assembly of a tripeptide precursor from three amino acids: L-alpha-aminoadipic acid, L-cysteine, and L-valine. A large multifunctional enzyme called ACV synthetase stitches these three amino acids together in a specific order, using ATP as an energy source, and flips the valine from its natural L-form to the D-form along the way.5PubMed. Penicillin biosynthesis: energy requirement for tripeptide precursor formation by delta-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine synthetase from Acremonium chrysogenum ACV synthetase belongs to a family of enzymes called nonribosomal peptide synthetases, which assemble peptides outside the normal protein-making machinery of the cell.6PubMed Central. Identification of a conserved N-terminal domain in the first module of ACV synthetases
The second step is the formation of the beta-lactam and thiazolidine rings. An enzyme called isopenicillin N synthase (encoded by the gene pcbC) takes the linear tripeptide and, using oxygen and iron, closes it into the bicyclic ring structure of isopenicillin N. This is the point where the molecule actually becomes a beta-lactam antibiotic, though isopenicillin N itself has limited antibacterial potency.
The third step swaps the side chain. Isopenicillin N carries an aminoadipyl side chain, which is hydrophilic and not very effective against most bacteria. An acyltransferase enzyme (encoded by penDE) removes this side chain and replaces it with a hydrophobic one, producing the clinically useful penicillins. If phenylacetic acid is available as a precursor, the product is penicillin G (benzylpenicillin). If phenoxyacetic acid is available, you get penicillin V.7PubMed Central. Molecular characterization of the acyl-coenzyme A:isopenicillin N acyltransferase gene (penDE) from Penicillium chrysogenum and Aspergillus nidulans and activity of recombinant enzyme in Escherichia coli The acyltransferase carries out this reaction without fully releasing the intermediate 6-aminopenicillanic acid (6-APA), instead directly converting isopenicillin N into the final product.8PubMed. The isopenicillin-N acyltransferase of Penicillium chrysogenum has isopenicillin-N amidohydrolase, 6-aminopenicillanic acid acyltransferase and penicillin amidase activities, all of which are encoded by the single penDE gene
The Bottleneck in Industrial Production
Modern penicillin production relies on industrial strains of P. chrysogenum that have been bred and engineered over decades to carry many copies of the penicillin biosynthetic gene cluster. More gene copies generally mean more penicillin, but the relationship is not linear. Research on high-yielding strains has shown that penicillin output increases with gene cluster copy number up to a point, then flattens out. The bottleneck turns out to be the acyltransferase step. Even when the genes for the earlier enzymes are cranked up and producing plenty of their products, the acyltransferase enzyme, which operates inside small cellular compartments called peroxisomes, reaches a ceiling. The number and size of those peroxisomes does not grow to match, so the final conversion step gets overwhelmed.9PubMed Central. Nonlinear biosynthetic gene cluster dose effect on penicillin production by Penicillium chrysogenum
This has practical implications for manufacturing. Simply adding more biosynthetic genes is not enough. Improving production further requires either boosting peroxisomal capacity or increasing the supply of co-substrates needed for the side-chain exchange reaction.
Semi-Synthetic Penicillins and the 6-APA Scaffold
The intermediate 6-APA, which sits at the junction between the beta-lactam core and whatever side chain is attached, turned out to be enormously useful for drug development. Chemists realized that by isolating 6-APA (either enzymatically from natural penicillin or through chemical cleavage) and then attaching novel side chains, they could create penicillins with new properties: broader antibacterial spectra, resistance to stomach acid for oral dosing, or activity against bacteria that had evolved defenses against natural penicillin.
This is how drugs like ampicillin, amoxicillin, and methicillin were born. They share the same beta-lactam/thiazolidine core but carry side chains designed to solve specific clinical problems. Recent work has continued pushing this approach, coupling 6-APA with new chemical groups to create penicillins with activity against difficult-to-treat bacteria. Some novel semi-synthetic penicillins have shown activity against Pseudomonas aeruginosa, a notoriously resistant gram-negative pathogen that standard amoxicillin cannot touch.10PubMed Central. New Semisynthetic Penicillins Obtained by Coupling of the 6-Aminopenicillanic Acid with 5-Mercapto-1,2,4-triazoles-3,4-disubstituted
How Bacteria Resist Penicillin
Resistance to penicillin is not a single trick. Bacteria have evolved multiple independent strategies, sometimes stacking several at once within the same organism.
Destroying the Drug With Beta-Lactamases
The most widespread resistance mechanism is enzymatic destruction. Bacteria produce enzymes called beta-lactamases that break open the beta-lactam ring before it can reach PBPs. Once the ring is hydrolyzed, the molecule can no longer form that covalent bond with its target, and it becomes harmless. There are four classes of beta-lactamases (A through D). Classes A, C, and D use an active-site serine residue to attack the ring. These serine beta-lactamases effectively treat the antibiotic as a substrate, temporarily bonding to it and then releasing the broken product.11PubMed Central. β-Lactam antibiotic targets and resistance mechanisms: from covalent inhibitors to substrates Class B beta-lactamases work differently, using zinc ions in their active sites to catalyze ring cleavage.12PubMed. Beta-lactamase (Class B1)
The clinical response to beta-lactamases has been to develop beta-lactamase inhibitors, compounds that bind to and block the enzyme so that the co-administered penicillin can reach its PBP target unhindered. The classic example is clavulanic acid, paired with amoxicillin in the combination known as Augmentin. Newer inhibitors are being developed to work against a broader range of beta-lactamases, including the carbapenemases that threaten some of the last-resort antibiotics.
Changing the Target
Rather than destroying penicillin, some bacteria alter the PBPs it tries to bind. The most clinically significant example is methicillin-resistant Staphylococcus aureus (MRSA). MRSA strains carry an acquired gene called mecA, which encodes an alternative penicillin-binding protein known as PBP2a. This enzyme takes over the wall cross-linking duties of the bacterium’s normal PBPs but has a much lower affinity for beta-lactam antibiotics, so penicillin essentially slides off it without forming a stable bond.13PubMed Central. Molecular Determinants of β-Lactam Resistance in Methicillin-Resistant Staphylococcus aureus (MRSA): An Updated Review PBP2a still catalyzes cell-wall cross-linking even while every other PBP in the cell is knocked out by the antibiotic, keeping the bacterium alive.14PubMed Central. Penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus
Blocking Entry
Some gram-negative bacteria resist penicillin not by destroying it or changing its target, but by preventing it from getting inside in the first place. Gram-negative organisms have an outer membrane that acts as a physical barrier, severely limiting the penetration of many antibiotics.15PubMed Central. Breaking the outer membrane barrier: structure, targets, and antimicrobial strategies for Gram-negative bacteria Penicillin must pass through protein channels called porins to cross this membrane. Mutations that narrow or alter porins can reduce the amount of drug that reaches the PBPs. In Neisseria gonorrhoeae, for example, a chromosomal mutation in the porin gene penB, combined with increased activity of an efflux pump, reduces the intracellular concentration of penicillin enough to confer resistance.16PubMed Central. Gonococcal resistance to beta-lactams and tetracycline involves mutation in loop 3 of the porin encoded at the penB locus
These three strategies can combine. A bacterium might produce a beta-lactamase and restrict porin entry simultaneously, creating layered defenses that make treatment extremely difficult.
Why Penicillin Works Better Against Some Bacteria Than Others
The gram-positive versus gram-negative divide matters enormously for penicillin’s effectiveness. Gram-positive bacteria like Staphylococcus and Streptococcus have a thick peptidoglycan layer exposed on their surface, making PBPs relatively accessible. Gram-negative bacteria like E. coli and Pseudomonas wrap their thinner peptidoglycan layer inside an outer membrane that penicillin must first penetrate. This is why natural penicillin G is highly effective against many gram-positive infections but has limited activity against gram-negative organisms. The broader-spectrum semi-synthetic penicillins, like ampicillin and the antipseudomonal penicillins, were specifically engineered with side chains that improve their passage through gram-negative outer membranes.
Penicillin Allergy and the Hapten Problem
Roughly one in ten people reports a penicillin allergy, though studies consistently show that the vast majority of those people are not truly allergic when formally tested. Still, genuine penicillin allergy exists and can be severe. The mechanism traces directly back to the same chemical reactivity that makes penicillin an effective antibiotic.
Penicillin molecules are too small on their own to trigger an immune response. But when the beta-lactam ring opens and bonds to a body protein (the same kind of ring-opening reaction that jams PBPs), the result is a new molecular structure the immune system may recognize as foreign. The penicilloyl group, formed when penicillin bonds to a carrier protein, is the primary trigger for allergic reactions.17PubMed. Penicilloyl peptides are recognized as T cell antigenic determinants in penicillin allergy In sensitized individuals, previous exposure has produced IgE antibodies specific to this penicilloyl-protein complex. On re-exposure, those antibodies trigger mast cells and basophils to release histamine and other inflammatory mediators, producing symptoms ranging from hives to anaphylaxis.18Primary Care: Clinics in Office Practice. Penicillin Allergy
The penicillin ring can also break down into other fragments, called minor determinants (penicilloate and penilloate), which less commonly cause reactions. This is one reason penicillin allergy testing uses multiple reagents rather than just one. It is also why the chemistry of penicillin’s instability, a liability in terms of shelf life, becomes a clinical concern in allergy.
Dosing Penicillin Effectively
Penicillin and other beta-lactams are “time-dependent” killers, meaning their effectiveness depends on how long the drug concentration stays above the level needed to inhibit bacterial growth, not on how high the peak concentration gets. This is a fundamental distinction from antibiotics like aminoglycosides, which kill more effectively at higher peak concentrations.
In critically ill patients, the stakes are higher because physiological changes can alter how the drug distributes through the body. Increased fluid volumes and accelerated kidney function can dilute the drug and clear it faster, raising the risk of underdosing. Research has shown that extended or continuous infusions of beta-lactams can help maintain drug levels above the inhibitory threshold for longer periods, improving outcomes compared to traditional short infusions given a few times a day.19PubMed Central. Pharmacokinetics-pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients
Testing Whether Bacteria Are Susceptible
Knowing how a particular bacterial isolate responds to penicillin requires laboratory testing. Several methods exist, and they do not always agree perfectly, which matters when the result determines treatment.
The traditional broth microdilution method exposes bacteria to a series of doubling concentrations of the antibiotic and identifies the minimum inhibitory concentration (MIC), the lowest concentration that prevents visible growth. This is considered the reference standard. Disk diffusion, where an antibiotic-impregnated paper disk is placed on an agar plate and the zone of inhibited growth around it is measured, is faster and cheaper but less precise. A newer approach, the Etest, combines features of both: a strip with a continuous gradient of antibiotic is placed on an inoculated plate, and the MIC is read directly where the zone of inhibition meets the strip. Comparative studies have found that the Etest achieves agreement with reference methods in over 94% of cases across a wide range of bacteria and antibiotics.20PubMed Central. Comparison of the E Test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria
These distinctions become clinically significant with organisms that sit near breakpoint thresholds. Certain Enterococcus faecalis strains, for example, are resistant to penicillin but susceptible to ampicillin, a distinction that disk diffusion handles poorly. In evaluations of these strains, the Etest proved accurate while disk diffusion gave unreliable results for some beta-lactams.21PubMed Central. Beta-lactams susceptibility testing of penicillin-resistant, ampicillin-susceptible Enterococcus faecalis isolates: a comparative assessment of Etest and disk diffusion methods against broth dilution For routine clinical work, the method used can actually change the treatment decision.
Penicillin’s Place in the Broader Beta-Lactam Family
Penicillins are just one branch of the beta-lactam family tree. Cephalosporins share the beta-lactam ring but fuse it to a six-membered dihydrothiazine ring instead of the five-membered thiazolidine ring found in penicillins, giving them different pharmacological properties and often broader activity. Carbapenems like imipenem and meropenem are structurally distinct again and are notable for being resistant to hydrolysis by most beta-lactamases, making them valuable last-resort drugs for multidrug-resistant infections.22PubMed Central. Carbapenems: past, present, and future Monobactams like aztreonam have a standalone beta-lactam ring with no second ring fused to it at all.
Despite this structural diversity, every member of the beta-lactam family works by the same fundamental mechanism: the beta-lactam ring opens and covalently disables a PBP. The variations in the rest of the molecule determine which PBPs are targeted most effectively, how well the drug penetrates different bacterial membranes, and how vulnerable it is to beta-lactamase attack. This shared logic is why resistance mechanisms that target the ring itself, like broad-spectrum beta-lactamases, threaten multiple drug classes simultaneously and why the development of new beta-lactamase inhibitors remains one of the most active areas in antibiotic research.